Jessica Darenberg
- Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine typesBy Sarah Browall, Erik Backhaus, Pontus Naucler, Ilias Galanis, Karin Sjöström, Diana Karlsson, Stefan Berg, Joachim Luthander, Margareta Eriksson, Carl Spindler, Mikael Ejdebäck, Birger Trollfors, Jessica Darenberg, Mats Kalin, Åke Örtqvist, Rune Andersson and Birgitta Henriques-NormarkArticle | Published in 2014 in European Respiratory JournalSarah Browall1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden12Both authors contributed equallyErik Backhaus2Dept of Infectious Diseases, Skaraborg Hospital, Skövde, Sweden12Both authors contributed equallyPontus Naucler1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden3Dept of Infectious Diseases, Karolinska University Hospital, Solna, SwedenIlias Galanis1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenKarin Sjöström1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenDiana Karlsson4Systems Biology Research Centre, School of Biosciences, University of Skövde, Skövde, SwedenStefan Berg5Queen Silvia Children’s Hospital, Sahlgrenska University Hospital, Gothenburg, SwedenJoachim Luthander6Dept of Paediatrics, Karolinska University Hospital, Solna, SwedenMargareta Eriksson6Dept of Paediatrics, Karolinska University Hospital, Solna, SwedenCarl Spindler3Dept of Infectious Diseases, Karolinska University Hospital, Solna, SwedenMikael Ejdebäck4Systems Biology Research Centre, School of Biosciences, University of Skövde, Skövde, SwedenBirger Trollfors5Queen Silvia Children’s Hospital, Sahlgrenska University Hospital, Gothenburg, SwedenJessica Darenberg7Public Health Agency of Sweden, Solna, SwedenMats Kalin3Dept of Infectious Diseases, Karolinska University Hospital, Solna, SwedenÅke Örtqvist8Dept of Communicable Diseases Control and Prevention, Stockholm County Council, Stockholm, Sweden9Dept of Medicine, Unit of Infectious Diseases, Karolinska Institutet, Solna, SwedenRune Andersson10Dept of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, SwedenBirgitta Henriques-Normark1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden11Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
- Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine typesBy Sarah Browall, Erik Backhaus, Pontus Naucler, Ilias Galanis, Karin Sjöström, Diana Karlsson, Stefan Berg, Joachim Luthander, Margareta Eriksson, Carl Spindler, Mikael Ejdebäck, Birger Trollfors, Jessica Darenberg, Mats Kalin, Åke Örtqvist, Rune Andersson and Birgitta Henriques-NormarkSarah Browall1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden12Both authors contributed equallyErik Backhaus2Dept of Infectious Diseases, Skaraborg Hospital, Skövde, Sweden12Both authors contributed equallyPontus Naucler1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden3Dept of Infectious Diseases, Karolinska University Hospital, Solna, SwedenIlias Galanis1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenKarin Sjöström1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenDiana Karlsson4Systems Biology Research Centre, School of Biosciences, University of Skövde, Skövde, SwedenStefan Berg5Queen Silvia Children’s Hospital, Sahlgrenska University Hospital, Gothenburg, SwedenJoachim Luthander6Dept of Paediatrics, Karolinska University Hospital, Solna, SwedenMargareta Eriksson6Dept of Paediatrics, Karolinska University Hospital, Solna, SwedenCarl Spindler3Dept of Infectious Diseases, Karolinska University Hospital, Solna, SwedenMikael Ejdebäck4Systems Biology Research Centre, School of Biosciences, University of Skövde, Skövde, SwedenBirger Trollfors5Queen Silvia Children’s Hospital, Sahlgrenska University Hospital, Gothenburg, SwedenJessica Darenberg7Public Health Agency of Sweden, Solna, SwedenMats Kalin3Dept of Infectious Diseases, Karolinska University Hospital, Solna, SwedenÅke Örtqvist8Dept of Communicable Diseases Control and Prevention, Stockholm County Council, Stockholm, Sweden9Dept of Medicine, Unit of Infectious Diseases, Karolinska Institutet, Solna, SwedenRune Andersson10Dept of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, SwedenBirgitta Henriques-Normark1Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden11Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
- Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, SwedenBy Ilias Galanis, Ann Lindstrand, Jessica Darenberg, Sarah Browall, Priyanka Nannapaneni, Karin Sjöström, Eva Morfeldt, Pontus Naucler, Margareta Blennow, Åke Örtqvist and Birgitta Henriques-NormarkArticle | Published in 2016 in European Respiratory JournalIlias Galanis1Public Health Agency of Sweden, Solna, Sweden10These authors contributed equally to this articleAnn Lindstrand1Public Health Agency of Sweden, Solna, Sweden2Dept of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden10These authors contributed equally to this articleJessica Darenberg1Public Health Agency of Sweden, Solna, Sweden10These authors contributed equally to this articleSarah Browall3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden4Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, SwedenPriyanka Nannapaneni3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenKarin Sjöström1Public Health Agency of Sweden, Solna, SwedenEva Morfeldt1Public Health Agency of Sweden, Solna, SwedenPontus Naucler5Dept of Medicine Solna, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden6Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, SwedenMargareta Blennow7Sachs’ Children's Hospital, South General Hospital, Stockholm, Sweden8Dept of Clinical Sciences and Education, Karolinska Institutet, Stockholm, SwedenÅke Örtqvist5Dept of Medicine Solna, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden9Dept of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden11These authors contributed equally to this articleBirgitta Henriques-Normark1Public Health Agency of Sweden, Solna, Sweden3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden4Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden11These authors contributed equally to this article
- Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, SwedenBy Ilias Galanis, Ann Lindstrand, Jessica Darenberg, Sarah Browall, Priyanka Nannapaneni, Karin Sjöström, Eva Morfeldt, Pontus Naucler, Margareta Blennow, Åke Örtqvist and Birgitta Henriques-NormarkArticle | Published in 2016 in European Respiratory JournalIlias Galanis1Public Health Agency of Sweden, Solna, Sweden10These authors contributed equally to this articleAnn Lindstrand1Public Health Agency of Sweden, Solna, Sweden2Dept of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden10These authors contributed equally to this articleJessica Darenberg1Public Health Agency of Sweden, Solna, Sweden10These authors contributed equally to this articleSarah Browall3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden4Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, SwedenPriyanka Nannapaneni3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenKarin Sjöström1Public Health Agency of Sweden, Solna, SwedenEva Morfeldt1Public Health Agency of Sweden, Solna, SwedenPontus Naucler5Dept of Medicine Solna, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden6Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, SwedenMargareta Blennow7Sachs’ Children's Hospital, South General Hospital, Stockholm, Sweden8Dept of Clinical Sciences and Education, Karolinska Institutet, Stockholm, SwedenÅke Örtqvist5Dept of Medicine Solna, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden9Dept of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden11These authors contributed equally to this articleBirgitta Henriques-Normark1Public Health Agency of Sweden, Solna, Sweden3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden4Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden11These authors contributed equally to this article
- Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, SwedenBy Ilias Galanis, Ann Lindstrand, Jessica Darenberg, Sarah Browall, Priyanka Nannapaneni, Karin Sjöström, Eva Morfeldt, Pontus Naucler, Margareta Blennow, Åke Örtqvist and Birgitta Henriques-NormarkIlias Galanis1Public Health Agency of Sweden, Solna, Sweden10These authors contributed equally to this articleAnn Lindstrand1Public Health Agency of Sweden, Solna, Sweden2Dept of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden10These authors contributed equally to this articleJessica Darenberg1Public Health Agency of Sweden, Solna, Sweden10These authors contributed equally to this articleSarah Browall3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden4Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, SwedenPriyanka Nannapaneni3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenKarin Sjöström1Public Health Agency of Sweden, Solna, SwedenEva Morfeldt1Public Health Agency of Sweden, Solna, SwedenPontus Naucler5Dept of Medicine Solna, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden6Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, SwedenMargareta Blennow7Sachs’ Children's Hospital, South General Hospital, Stockholm, Sweden8Dept of Clinical Sciences and Education, Karolinska Institutet, Stockholm, SwedenÅke Örtqvist5Dept of Medicine Solna, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden9Dept of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden11These authors contributed equally to this articleBirgitta Henriques-Normark1Public Health Agency of Sweden, Solna, Sweden3Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden4Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden11These authors contributed equally to this article
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.